Sagimet Biosciences Inc.
HealthcareNASDAQ:SGMT · NASDAQ Global Market
+$0.05 today
Vol 0.46M · Avg 1.48M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-21.64%
Period High
$10.24
Period Low
$4.55
Latest
$6.48
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$566.68M
Assembly Biosciences, Inc.
NASDAQ:ASMB
$364.90M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$359.32M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$245.42M
Zura Bio Limited
NASDAQ:ZURA
$240.58M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$211.47M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$198.11M
Humacyte, Inc.
NASDAQ:HUMA
$177.24M
Immuneering Corporation
NASDAQ:IMRX
$152.11M
What is the latest SGMT filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does SGMT have?
Intrinsic Alpha currently shows 20 recent filings for SGMT.
Explore More
Continue the stock analysis
Jump to another research area for this company.